These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2511636)

  • 41. [Indications of blood components and outcome of transfusion practices in hemorrhage of multiple trauma].
    Audibert G
    Cah Anesthesiol; 1994; 42(3):391-4. PubMed ID: 7812868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment with blood and blood plasma fractions].
    Weise W
    Dtsch Med J; 1967 Feb; 18(3):63-6. PubMed ID: 4174358
    [No Abstract]   [Full Text] [Related]  

  • 43. Rationale for blood component therapy.
    Steinbronn K; Huestis DW
    Contemp Anesth Pract; 1983; 6():151-67. PubMed ID: 6337017
    [No Abstract]   [Full Text] [Related]  

  • 44. [Modification of hemorrheologic and laboratory chemical parameters by infusion therapy and preserved serum and by plasma exchange with human albumin and preserved serum in patients with posterior and intermediate uveitis].
    Jahn M; Brunner R; Borberg H; Kadar J; Kreutzer A; Hossmann V
    Fortschr Ophthalmol; 1988; 85(6):740-3. PubMed ID: 3220395
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of blood and blood components for feline and canine patients.
    Killingsworth CR
    J Am Vet Med Assoc; 1984 Dec; 185(11):1452-4. PubMed ID: 6511618
    [No Abstract]   [Full Text] [Related]  

  • 46. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of peripheral blood components on allograft survival.
    Wakely E; Shelby J; Corry RJ
    Transplantation; 1985 Jul; 40(1):113-4. PubMed ID: 3892790
    [No Abstract]   [Full Text] [Related]  

  • 48. [Transfusion of blood and blood derivatives. Immunological bases and indications].
    Janot C
    Rev Prat; 1994 Dec; 44(19):2639-45. PubMed ID: 7855535
    [No Abstract]   [Full Text] [Related]  

  • 49. [Blood transfusion and blood-derived products transfusion. Immunologic principles and indications].
    Lamy B; Morel P; Hervé P
    Rev Prat; 1998 Mar; 48(5):549-53. PubMed ID: 9781121
    [No Abstract]   [Full Text] [Related]  

  • 50. The hospital transfusion committee. Guidelines for improving practice.
    Grindon AJ; Tomasulo PA; Bergin JJ; Klein HG; Miller JD; Mintz PD
    JAMA; 1985 Jan; 253(4):540-3. PubMed ID: 3918182
    [No Abstract]   [Full Text] [Related]  

  • 51. The appropriate use of diagnostic services: (XV). A guide to blood transfusion practice.
    Smith DS
    Health Bull (Edinb); 1988 Jan; 46(1):8-17. PubMed ID: 3350658
    [No Abstract]   [Full Text] [Related]  

  • 52. TRANSFUSION OF BLOOD FRACTIONS.
    SALSBURY AJ
    Practitioner; 1965 Aug; 195():193-200. PubMed ID: 14328859
    [No Abstract]   [Full Text] [Related]  

  • 53. Transfusion of specific plasma components.
    Tullis JL; Pennell RB
    Annu Rev Med; 1968; 19():233-46. PubMed ID: 4172726
    [No Abstract]   [Full Text] [Related]  

  • 54. Transfusion support for leukaemia and oncology patients.
    Mayer K
    Clin Haematol; 1984 Feb; 13(1):93-8. PubMed ID: 6373084
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New trends in blood component therapy.
    Högman CF
    Haematologia (Budap); 1983; 16(1-4):23-38. PubMed ID: 6383964
    [No Abstract]   [Full Text] [Related]  

  • 57. [Preparation and use of thrombocyte and leukocyte concentrations].
    Grgicević D
    Lijec Vjesn; 1978 Jun; 100(6):392-3. PubMed ID: 703501
    [No Abstract]   [Full Text] [Related]  

  • 58. The chronically transfused patient: advances in treatment.
    McCullough J; Jacob HS
    Hosp Pract (Off Ed); 1985 Jul; 20(7):77-84. PubMed ID: 3924941
    [No Abstract]   [Full Text] [Related]  

  • 59. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
    Andersen O
    Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemophilia--darkest hours before the dawn.
    Street AM; Ekert H
    Med J Aust; 1996 Apr; 164(8):453-5. PubMed ID: 8614331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.